[[Image:Stumpfungus.jpg|thumb|''Trametes versicolor'', the mushroom from which PSK was isolated.]]
'''Polysaccharide-K''' ('''Krestin''', '''PSK''') is a [[protein]]-bound [[polysaccharide]], which is utilized as an anticancer [[immunologic adjuvant]] in some countries. Japan began using PSK in 1977<ref name="psk">
{{cite web
 |url=http://www.cancer.org/docroot/ETO/content/ETO_5_3X_Coriolous_Versicolor.asp
 |title=Coriolus Versicolor
 |publisher=American Cancer Society
 |accessdate=12 July 2009
}}</ref> and it is presently covered by government health insurance. 

PSK is isolated from the fruitbody of ''[[Trametes versicolor]]''. Preliminary evidence indicates PSK has anticancer activity ''[[in vitro]]'',<ref name="pmid18366723">{{cite journal |author=Jiménez-Medina E, Berruguilla E, Romero I et al. |title=The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis |journal=BMC Cancer |volume=8|pages=78 |year=2008 |pmid=18366723 |pmc=2291471 |doi=10.1186/1471-2407-8-78}}</ref> ''[[in vivo]]''<ref name="pmid19414318">{{cite journal |author=Yamasaki A, Shoda M, Iijima H et al. |title=A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model |journal=Anticancer Research |volume=29 |issue=3 |pages=843–50 |year=2009 |month=March |pmid=19414318 |url=http://ar.iiarjournals.org/cgi/pmidlookup?view=long&pmid=19414318}}</ref> and in human clinical trials.<ref name="pmid17106715">{{cite journal |author=Oba K, Teramukai S, Kobayashi M, Matsui T, Kodera Y, Sakamoto J |title=Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer |journal=Cancer Immunology, Immunotherapy |volume=56 |issue=6 |pages=905–11 |year=2007 |month=June |pmid=17106715 |doi=10.1007/s00262-006-0248-1}}</ref> Preliminary research has also demonstrated that PSK may inhibit various cancer onset mechanisms.<ref name="pmid7606203">{{cite journal |author=Kobayashi H, Matsunaga K, Oguchi Y |title=Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview |journal=Cancer Epidemiology, Biomarkers & Prevention |volume=4 |issue=3 |pages=275–81 |year=1995 |pmid=7606203 |url=http://cebp.aacrjournals.org/cgi/pmidlookup?view=long&pmid=7606203}}</ref> Preliminary evidence indicates PSK may have use as an adjuvant in the treatment of gastric, esophageal, colorectal, breast and lung cancers.<ref name="pmid12168863">{{cite journal |author=Fisher M, Yang LX |title=Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy |journal=Anticancer Research |volume=22 |issue=3 |pages=1737–54 |year=2002 |pmid=12168863}}</ref>  Human clinical trials suggest PSK may affect cancer recurrence when used as an adjuvant,<ref name="pmid17106715"/><ref name="pmid9219507">{{cite journal |author=Sugimachi K, Maehara Y, Ogawa M, Kakegawa T, Tomita M |title=Dose intensity of uracil and tegafur in postoperative chemotherapy for patients with poorly differentiated gastric cancer |journal=Cancer Chemotherapy and Pharmacology |volume=40 |issue=3 |pages=233–8 |year=1997 |pmid=9219507 |doi=10.1007/s002800050652}}</ref> and basic research has demonstrated it inhibited certain human cancer cell lines ''in vitro''.<ref name="pmid11115542">{{cite journal |author=Hsieh TC, Wu JM |title=Cell growth and gene modulatory activities of Yunzhi (Windsor Wunxi) from mushroom Trametes versicolor in androgen-dependent and androgen-insensitive human prostate cancer cells |journal=International Journal of Oncology |volume=18 |issue=1 |pages=81–8 |year=2001 |month=January |pmid=11115542}}</ref><ref name="pmid9042394">{{cite journal |author=Dong Y, Yang MM, Kwan CY |title=In vitro inhibition of proliferation of HL-60 cells by tetrandrine and coriolus versicolor peptide derived from Chinese medicinal herbs |journal=Life Sciences |volume=60 |issue=8 |pages=PL135–40 |year=1997 |pmid=9042394 |doi=10.1016/S0024-3205(96)00695-9}}</ref><ref name="pmid1471606 ">{{cite journal |author=Yang MM, Chen Z, Kwok JS |title=The anti-tumor effect of a small polypeptide from Coriolus versicolor (SPCV) |journal=The American Journal of Chinese Medicine |volume=20 |issue=3–4 |pages=221–32 |year=1992 |pmid=1471606 |doi=10.1142/S0192415X92000230}}</ref>

The [[MD Anderson Cancer Center]] reported that it is a "promising candidate for chemoprevention due to the multiple effects on the malignant process, limited side effects and safety of daily oral doses for extended periods of time."<ref name="mdanderson/ucsd">
{{cite web
 |url=http://cancer.ucsd.edu/Outreach/PublicEducation/CAMs/coriolusversicolor.asp
 |publisher=University of California
 |location=San Diego
 |work=Complementary and alternative therapies for cancer patients
 |title=Coriolus versicolor
}}</ref>  The [[Therapeutic Goods Administration]] in Australia reported that the [[World health organization|WHO]] has only eight records of adverse effects with PSK and none reported for PSP.<ref>http://www.tga.gov.au/docs/pdf/cmec/cmecmi55.pdf</ref>

==Research summary==
In conjunction with [[chemotherapy]], PSK has increased the survival time of cancer patients in randomized, control studies, with stomach cancer (meta-analysis of 8,009 patients),<ref name="pmid17106715"/> colorectal cancer (randomized, controlled study of 448 patients),<ref name="pmid1735313">{{cite journal |author=Mitomi T, Tsuchiya S, Iijima N, ''et al.'' |title=Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa) |journal=Diseases of the Colon and Rectum |volume=35 |issue=2 |pages=123–30 |year=1992 |month=February |pmid=1735313 |doi=10.1007/BF02050666}}</ref> non-small cell lung carcinoma,<ref>{{cite journal |author=Hayakawa K, Mitsuhashi N, Saito Y, ''et al.'' |title=Effect of Krestin as adjuvant treatment following radical radiotherapy in non-small cell lung cancer patients |journal=Cancer Detection and Prevention |volume=21 |issue=1 |pages=71–7 |year=1997 |pmid=9043766}}</ref> and small cell carcinoma of the lungs. PSK has produced mixed results with breast cancer,<ref name=pmid8669887>{{cite journal |author=Iino Y, Yokoe T, Maemura M, ''et al.'' |title=Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer |journal=Anticancer Research |volume=15 |issue=6B |pages=2907–11 |year=1995 |pmid=8669887}}</ref> liver cancer,<ref name=pmid8137477>{{cite journal |author=Suto T, Fukuda S, Moriya N, ''et al.'' |title=Clinical study of biological response modifiers as maintenance therapy for hepatocellular carcinoma |journal=Cancer Chemotherapy and Pharmacology |volume=33 Suppl |issue= |pages=S145–8 |year=1994 |pmid=8137477}}</ref> and leukemia.<ref name=pmid6391658>{{cite journal |author=Ohno R, Yamada K, Masaoka T, ''et al.'' |title=A randomized trial of chemoimmunotherapy of acute nonlymphocytic leukemia in adults using a protein-bound polysaccharide preparation |journal=Cancer Immunology, Immunotherapy |volume=18 |issue=3 |pages=149–54 |year=1984 |pmid=6391658 |doi=10.1007/BF00205503}}</ref> Research has shown PSK can help to restore the [[immune system]] of immuno-deficient animals,<ref>{{cite journal |author=Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K, Orita K |title=Krestin (PSK) |journal=Cancer Treatment Reviews |volume=11 |issue=2 |pages=131–55 |year=1984 |month=June |pmid=6238674 |doi=10.1016/0305-7372(84)90005-7}}</ref> and ''in vitro'' research indicates PSK may enhance the activity of [[doxorubicin]] and [[etoposide]].<ref name="pmid18292947">{{cite journal| author=Wan JM, Sit WH, Louie JC| title=Polysaccharopeptide enhances the anticancer activity of doxorubicin and etoposide on human breast cancer cells ZR-75-30 | journal=Int J Oncol | year= 2008 | volume= 32 | issue= 3 | pages= 689–99 | pmid=18292947 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref><ref name="pmid15944782">{{cite journal| author=Hui KP, Sit WH, Wan JM| title=Induction of S phase cell arrest and caspase activation by polysaccharide peptide isolated from Coriolus versicolor enhanced the cell cycle dependent activity and apoptotic cell death of doxorubicin and etoposide, but not cytarabine in HL-60 cells | journal=Oncol Rep | year= 2005 | volume= 14 | issue= 1 | pages= 145–55 | pmid=15944782 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref>

{| class="wikitable" style="text-align:center"; border="1"
! Tissue !! Cancer cell line !! Reported effect of PSK<ref name="pmid7606203"/> 
|-
|Lung (spontaneous metastasis)|| autochthonous tumor || Increased survival time
|-
|Lung (spontaneous metastasis)||  human prostate cancer (DU-145M, PC-3M) || Increased survival time
|-
|Lung (spontaneous metastasis)||  mouse melanoma (B16-BL6) || Increased survival time
|-
|Lung (spontaneous metastasis)||  rat lung cancer || Increased survival time
|-
|Liver (spontaneous metastasis)||  human lung cancer (AOI) || Suppressed lesion growth
|-
|Lymph nodes (spontaneous metastasis)||  mouse leukemia (P388) || Increased survival time
|-
| Lymph nodes (spontaneous metastasis)||  mouse liver cancer (MH134) || Suppressed lesion growth
|-
|Liver (artificial metastasis)||  rat liver cancer (AH60C) || Suppressed lesion growth
|-
|Liver (artificial metastasis)||  mouse leukemia  || Suppressed lesion growth
|-
|Liver (artificial metastasis)||  mouse colon cancer || Suppressed lesion growth and increased survival time
|-
|}

==PSK chemistry==
PSK is a protein polysaccharide consisiting of a [[beta-glucan]] β-1,4 main chain with β-1,3 and β-1,6 side chains. The approximate molecular weight of PSK is 100,000 [[Atomic mass unit|Da]], and the protein component is reported at the β-1,6 side chain.<ref name="pmid7606203"/> PSK is isolated from the "CM-101" strain of ''Trametes versicolor''. The analogous compound [[Polysaccharide Peptide|PSP]], is derived from the "COV-1" strain of ''Trametes versicolor''.<ref name="pmid12168863"/>

==See also==
*[[Coriolus versicolor]]
*[[Medicinal mushrooms]]
*[[Polysaccharide Peptide]]
{{Portal|Fungi}}

==References==

{{Reflist|2}}

==External links==
*American Cancer Society's page for [http://www.cancer.org/docroot/eto/content/eto_5_3x_coriolous_versicolor.asp ''Trametes versicolor'' and Polysaccharide-K].
*Memorial Sloan-Kettering Cancer Center's page for [http://www.mskcc.org/mskcc/html/69194.cfm ''Trametes versicolor'' and Polysaccharide-K].
*A [http://www.mdanderson.org/education-and-research/resources-for-professionals/clinical-tools-and-resources/cimer/therapies/herbal-plant-biologic-therapies/coriolus-versicolor-scientific.html "Detailed Scientific Review of ''Trametes versicolor'' and Polysaccharide-K"] by the MD Anderson Cancer Center.
*[http://www.drugs.com/npp/turkey-tail.html ''Trametes versicolor'' and Polysaccharide-K] information from Drugs.com.

[[Category:Medicinal fungi]]